GO
Loading...

Health Care Equipment

More

  • WASHINGTON, Nov 26- Medtronic Inc has won U.S. antitrust approval to buy Dublin- based Covidien Plc on condition that it sell its drug-coated balloon catheter business, the Federal Trade Commission said on Wednesday. Medtronic and Covidien shareholders will vote on the merger on Jan. 6. Medtronic is the world's largest stand-alone medical device maker, with a...

  • I believe in Obamacare: Mount Sinai Health CEO Saturday, 22 Nov 2014 | 12:00 PM ET
    Signage hangs outside Mount Sinai Hospital on August 4, 2014 in New York City.

    Despite the endless controversies dogging Obamacare, the CEO of Mount Sinai believes the legislation is meeting many of its goals.

  • WASHINGTON, Nov 12- Republicans in the U.S. Congress will soon move to kill a medical device tax imposed less than two years ago under President Barack Obama's healthcare law, congressional aides and analysts said on Wednesday. Though no full-scale repeal of Obamacare is expected, even with the Senate now under Republican control, the move against the tax is part...

  • Republican knives out for Obama's medical devices tax Wednesday, 12 Nov 2014 | 5:25 PM ET

    Last week's elections will elevate Republican Senator Orrin Hatch, a long-standing opponent of the tax, to the chairmanship of the tax-writing finance committee in the Senate. Though no full-scale repeal of Obamacare is expected, even with the Senate under Republican control, the move against the device tax is part of efforts to chip away at the law.

  • Nov 11- A U.S. federal court has ordered medical device maker Becton Dickinson and Co to notify customers that it falsely claimed its safety syringes were sharper and wasted less medicine than those of rival Retractable Technologies Inc.. The order, handed down Monday by Judge Leonard Davis in the Eastern District of Texas, follows an award of $340 million in...

  • CORRECTED-Stryker settles hip implants lawsuit Monday, 3 Nov 2014 | 8:04 PM ET

    Nov 3- Orthopedics company Stryker Corp said its settled a compensation lawsuit related to its hip implant, and said it did not expect the settlement to hurt its profit. Stryker will provide a base payment of $300,000 to patients who received the implant and underwent revision surgery by Nov. 3, to remove and replace the devices, plaintiffs' counsel Wendy...

  • Stryker settles hip implants lawsuit Monday, 3 Nov 2014 | 5:52 PM ET

    Nov 3- Orthopedics company Stryker Corp said its settled a compensation lawsuit related to its hip implant, and said it did not expect the settlement to hurt its profit. Stryker will provide a base payment of $300,000 to patients who received the implant and underwent revision surgery by Nov. 3, to remove and replace the devices, plaintiffs' counsel Wendy...

  • Oct 22- Boston Scientific Corp on Wednesday posted a third-quarter profit on increased sales of its implantable heart devices and raised its full-year revenue outlook, sending its shares up more than 3 percent. Sales of cardiac rhythm management devices, including implantable defibrillators and pacemakers, rose 3 percent to $480 million from a year earlier.

  • BOSTON, Oct 22- The U.S. Department of Homeland Security is investigating about two dozen cases of suspected cybersecurity flaws in medical devices and hospital equipment that officials fear could be exploited by hackers, a senior official at the agency told Reuters. The products under review by the agency's Industrial Control Systems Cyber Emergency...

  • Oct 15- Heart device maker St. Jude Medical Inc forecast a quarterly revenue that fell below Wall Street estimate, and said sales growth in international markets didn't match its expectation. The maker of pacemakers, implantable defibrillators, artificial heart valves, stents and neurological products said it expects an adjusted profit of $1.02- $1.04 per...

  • ConvaTec owners appoint banks to explore sale - sources Wednesday, 15 Oct 2014 | 6:17 AM ET

    LONDON, Oct 15- ConvaTec's owners have appointed Morgan Stanley and Goldman Sachs to explore a sale of the medical device maker which could be worth up to $10 billion, sources familiar with the matter said. Private equity firms Avista Capital Partners and Nordic Capital are preparing the groundwork for a possible sale or initial public offering in 2015 for the...

  • First Ebola vaccine trial starts in Africa Thursday, 9 Oct 2014 | 7:29 PM ET

    The first trial of an Ebola vaccine has started with the vaccination of three health care workers in Mali, researchers told NBC News.

  • DALLAS, Oct 7- The Ebola patient fighting for his life in a Dallas hospital is on a ventilator and a kidney dialysis machine to help stabilize his health, the hospital said on Tuesday. Authorities in the United States and the public are on alert following Duncan's diagnosis more than a week ago, which raised concerns that the worst epidemic of Ebola on record could...

  • Intel’s Basis takes second stab at health watch Tuesday, 30 Sep 2014 | 12:52 PM ET
    Basis Peak watch

    Another day, another new wrist-wearable in gadgetland. But this one sounds … pretty compelling. Re/code explains.

  • An Ebola vaccine? 'There's no money in it.' Monday, 4 Aug 2014 | 10:56 AM ET
    Medical staff put on protective gear at Kenema Government Hospital before taking a sample from a suspected Ebola patient in Kenema, Sierra Leone.

    The death toll from the Ebola virus in West Africa keeps growing to record levels. And ironically, that may be why there's no vaccine, said an expert.

  • Taking on the Luxottica eyewear machine Tuesday, 17 Jun 2014 | 6:00 AM ET
    Neil Blumenthal (left) and David Gilboa, co-founders of Warby Parker

    A David taking on retail Golaiths, this e-commerce upstart is circumventing traditional channels and selling eyeglasses to the masses.

  • Medtronic mulls bid for Smith & Nephew: Report Wednesday, 4 Jun 2014 | 3:36 PM ET
    Medtronic office in Toronto.

    One of the world's largest makers of medical devices, Medtronic, is considering a takeover of London-based Smith & Nephew, Bloomberg said.

  • AstraZeneca Chair: Shareholders, 'vote me away' Monday, 19 May 2014 | 11:14 AM ET

    As AstraZeneca's shares slid following its rejection of Pfizer's new bid, the company's chairman said he was "reasonably confident" it was the right decision.

  • Boston Scientific subpoenaed over heart device Friday, 9 May 2014 | 6:25 AM ET
    U.S. Department of Health and Human Services building, Washington, DC.

    Boston Scientific received a subpoena this week from the Department of Health and Human Services seeking information about its defibrillators.

  • J&J beats forecasts, helped by new medicines Tuesday, 15 Apr 2014 | 10:06 AM ET

    Johnson & Johnson turned in a solid first quarter Tuesday, topping analysts' profit and revenue estimates and increasing its 2014 earnings forecast by 5 cents a share.